Weekly paclitaxel (WP) plus /- bevacizumab (B) in angiosarcoma (AS) patients (pts): Analysis of prognostic/predictive factors from a randomized phase 2 trial.

Affiliation auteurs!!!! Error affiliation !!!!
TitreWeekly paclitaxel (WP) plus /- bevacizumab (B) in angiosarcoma (AS) patients (pts): Analysis of prognostic/predictive factors from a randomized phase 2 trial.
Type de publicationJournal Article
Year of Publication2017
AuteursLebellec L, Bertucci F, Tresch-Bruneel E, Ray-Coquard ILaure, Le Cesne A, Bompas E, Piperno-Neumann S, Italian A, Chevreau C, Cupissol D, Bay J-O, Collard O, Saada-Bouzid E, Isambert N, Delcambre C, Blay J-Y, Goncalves A, Penel N
JournalJOURNAL OF CLINICAL ONCOLOGY
Volume35
Date PublishedMAY 20
Type of ArticleMeeting Abstract
ISSN0732-183X
DOI10.1200/JCO.2017.35.15_suppl.11024